Potassium Chloride In Dextrose And Sodium Chloride Injection, Solution
Product Images NDC 0990-7993

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Potassium Chloride In Dextrose And Sodium Chloride (NDC 0990-7993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Icu Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Dextrose (Potassium 01)

Structural Formula Dextrose (Potassium 01)
Chemical structure diagram depicting the molecular arrangement of Dextrose Monohydrate, showing the glucose ring with hydroxyl groups and a water molecule associated (H2O).*
FDA Label Image

Principal Display Panel (1000 mL Bag Label)

Principal Display Panel (1000 mL Bag Label)
Potassium Chloride 20 mEq in 5% Dextrose and 0.9% Sodium Chloride Injection, USP in a 1000 mL single-dose container. The label lists ingredients and electrolyte content per 100 mL and 1000 mL, with pH and storage instructions. Manufactured by ICU Medical Inc., Lake Forest, Illinois, USA.*
FDA Label Image

Principal Display Panel (1000 mL Bag Label)

Principal Display Panel (1000 mL Bag Label)
Label for Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection, USP, 40 mEq strength in a 1000 mL vial. The label includes concentration details, NDC 0990-7109-09, manufacturer ICU Medical Inc., and usage instructions emphasizing sterile, single-dose container for intravenous use only.*
FDA Label Image

Principal Display Panel (1000 mL Bag Label)

Principal Display Panel (1000 mL Bag Label)
Potassium Chloride 30 mEq in 5% Dextrose and 0.45% Sodium Chloride injection, USP, 1000 mL intravenous solution. The label shows the active ingredients' concentrations and usage instructions, including additive incompatibility warnings. Manufactured by ICU Medical Inc.*
FDA Label Image

Principal Display Panel (1000 mL Bag Label)

Principal Display Panel (1000 mL Bag Label)
Label for Potassium Chloride injection solution with strength 40 mEq per 1000 mL in 5% Dextrose and 0.45% Sodium Chloride. The image includes detailed composition, usage instructions, and manufacturer ICU Medical Inc. It states this is a single-dose, sterile intravenous solution with additives warnings and storage instructions.*
FDA Label Image

Principal Display Panel (1000 mL Bag Label)

Principal Display Panel (1000 mL Bag Label)
Label for Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL intravenous solution. The label highlights 10 mEq Potassium Chloride, lists electrolyte contents per 100 mL, and includes usage instructions, storage precautions, and manufacturer ICU Medical Inc., Lake Forest, Illinois.*
FDA Label Image

Principal Display Panel (1000 mL Bag Label)

Principal Display Panel (1000 mL Bag Label)
Label for Potassium Chloride 20 mEq in 1000 mL injection solution containing 5% Dextrose and 0.225% Sodium Chloride, USP. The label includes the NDC 0990-7901-09 and notes that each 100 mL contains potassium chloride, sodium chloride, and dextrose. Manufactured by ICU Medical Inc., Lake Forest, Illinois, USA. The label also includes warnings about additive compatibility, single-dose use, and storage instructions.*
FDA Label Image

Principal Display Panel (500 mL Bag Label)

Principal Display Panel (500 mL Bag Label)
Potassium Chloride injection label showing 10 mEq potassium in 500 mL. The solution contains 0.45% Sodium Chloride and 5% Dextrose, USP. The label includes usage information, electrolyte content per 100 mL, storage and handling instructions, and manufacturer details: ICU Medical Inc., Lake Forest, Illinois. The packaging also displays Latex and DEHP content warnings.*
FDA Label Image

Principal Display Panel (Overwrap)

Principal Display Panel (Overwrap)
A text panel providing handling instructions for a medication container. It advises to tear open at the notch, not to remove from overwrap until ready for use, to check for leaks by squeezing, discard if leaks are found, storage recommendations of room temperature (25°C), avoiding heat and freezing, and to see the insert for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.